Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High concentration formulation developability approaches and considerations
Jonathan Zarzar, Tarik A. Khan, Maniraj Bhagawati, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability
Habib Bashour, Eva Smorodina, Matteo Pariset, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Pharmacokinetics‐Based Design of Subcutaneous Controlled Release Systems for Biologics
Abigail K. Grosskopf, Antonio A. Ginart, Phillip C. Spinosa, et al.
CPT Pharmacometrics & Systems Pharmacology (2025)
Open Access
Trends and Challenges in Bispecific Antibody Production
Mikhail S. Karbyshev, Irina Kalashnikova, Veronika Dubrovskaya, et al.
Journal of Chromatography A (2025), pp. 465722-465722
Closed Access
DyAb: sequence-based antibody design and property prediction in a low-data regime
Joshua Lin, Jennifer L. Hofmann, Andrew Leaver‐Fay, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Molecular surface descriptors to predict antibody developability: sensitivity to parameters, structure models, and conformational sampling
Eliott Park, Saeed Izadi
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Quantifying Protein Shape to Elucidate Its Influence on Solution Viscosity in High-Concentration Electrolyte Solutions
Tian Zhou, Xuling Jiang, Zhidong Chen, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 1719-1728
Closed Access | Times Cited: 3
Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volume
Mukesh Desai, Amit Kundu, Michiel Hageman, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 10
The history and potential future of monoclonal antibody therapeutics development and manufacturing in four eras
Brian D. Kelley
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Advancing Subcutaneous Dosing Regimens for Biotherapeutics: Clinical Strategies for Expedited Market Access
Beate Bittner, Johannes Schmidt
BioDrugs (2023) Vol. 38, Iss. 1, pp. 23-46
Open Access | Times Cited: 8
Correlating Surface Activity with Interface-Induced Aggregation in a High-Concentration mAb Solution
Estephanie Laura Nottar Escobar, Valerie P. Griffin, Prajnaparamita Dhar
Molecular Pharmaceutics (2024) Vol. 21, Iss. 3, pp. 1490-1500
Closed Access | Times Cited: 2
Stability of Protein Pharmaceuticals: Recent Advances
Mark C. Manning, Ryan E. Holcomb, R. W. Payne, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 7, pp. 1301-1367
Closed Access | Times Cited: 2
Rapid Characterization of Structural and Behavioral Changes of Therapeutic Proteins by Relaxation and Diffusion 1H-SOFAST NMR Experiments
Xingjian Xu, Guilherme Dal Poggetto, Mark A. McCoy, et al.
(2024)
Open Access | Times Cited: 2
The contrasting roles of co-solvents in protein formulations and food products
Tsutomu Arakawa, Yui Tomioka, Teruo Akuta, et al.
Biophysical Chemistry (2024) Vol. 312, pp. 107282-107282
Closed Access | Times Cited: 1
Real‐Time Observation of Protein Aggregation at Liquid‐Liquid Interfaces in a Microfluidic Device
Dominik Zürcher, Klaus Wuchner, Paolo Arosio
Small (2024) Vol. 20, Iss. 45
Open Access | Times Cited: 1
Roadmap for Drug Product Development and Manufacturing of Biologics
Krishnan Sampathkumar, Bruce A. Kerwin
Journal of Pharmaceutical Sciences (2023) Vol. 113, Iss. 2, pp. 314-331
Open Access | Times Cited: 4
Molecular Surface Descriptors to Predict Antibody Developability
Eliott Park, Saeed Izadi
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability
Habib Bashour, Eva Smorodina, Matteo Pariset, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Monoclonal Antibodies from Space: Improved Crystallization Under Microgravity During Manufacturing in Orbit
Shimon Amselem, Daniel Kogan, Offir Loboda, et al.
Journal of Exploratory Research in Pharmacology (2024) Vol. 9, Iss. 2, pp. 96-105
Open Access
Navigating large-volume subcutaneous injections of biopharmaceuticals: a systematic review of clinical pipelines and approved products
Philip Green, Andreas Schneider, Jakob Lange
mAbs (2024) Vol. 16, Iss. 1
Open Access
Impact of Surface Tension, Viscosity, Pump Settings, and Nozzle Size on Filling Process Capability and Accuracy in High-Concentration Biopharmaceuticals
Qizhou Chen, Chenxi Wang, Tingting Wang, et al.
Journal of Pharmaceutical Sciences (2024)
Closed Access
Development and validation of a robust RP-HPLC method to quantitate residual 2–mercaptoethylamine in drug product formulations containing amino acid additives
D.G. Doran, Geoffrey T. Struble, Katarina Moravcevic, et al.
Journal of Chromatography B (2024) Vol. 1249, pp. 124379-124379
Open Access
Hybrid Mass Spectrometry Applied across the Production of Antibody Biotherapeutics
Emilia Christofi, Mark O’Hanlon, Robin Curtis, et al.
Journal of the American Society for Mass Spectrometry (2024)
Open Access
Advancements in mammalian display technology for therapeutic antibody development and beyond: current landscape, challenges, and future prospects
Peter Slavny, Manjunath Hegde, Achim Doerner, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Rapid Characterization of Structural and Behavioral Changes of Therapeutic Proteins by Relaxation and Diffusion 1H-SOFAST NMR Experiments
Xingjian Xu, Guilherme Dal Poggetto, Mark A. McCoy, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 41, pp. 16322-16329
Closed Access
Discovery of a common light chain bispecific antibody targeting PD-1 and PD-L1 by Hybridoma-to-phage-to-yeast (H2PtY) platform
Peipei Liu, Chunyin Gu, Xiaodan Cao, et al.
Antibody Therapeutics (2024) Vol. 8, Iss. 1, pp. 1-12
Open Access
Page 1 - Next Page

Scroll to top